AQP1
Basic information
Region (hg38): 7:30911853-30925517
Previous symbols: [ "CO" ]
Links
Phenotypes
GenCC
Source:
- pulmonary arterial hypertension (Limited), mode of inheritance: AD
- pulmonary arterial hypertension (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Blood group, Colton | BG | Hematologic | Variants associated with a blood group may be important in specific situations (eg, related to transfusion) | Hematologic | 7521540; 7521882; 11606828; 11463012; 11773634 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AQP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 14 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 11 | 14 | ||||
Total | 0 | 0 | 15 | 13 | 17 |
Variants in AQP1
This is a list of pathogenic ClinVar variants found in the AQP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-30911929-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
7-30911938-T-G | not specified | Uncertain significance (Dec 27, 2023) | ||
7-30911956-C-T | not specified | Uncertain significance (May 24, 2024) | ||
7-30911971-C-T | not specified | Likely benign (Mar 21, 2023) | ||
7-30911974-C-A | Uncertain significance (Jul 25, 2021) | |||
7-30912022-C-T | Colton-null phenotype | Pathogenic (Sep 09, 1994) | ||
7-30912023-G-A | Benign (Dec 08, 2023) | |||
7-30912043-C-T | COLTON BLOOD GROUP POLYMORPHISM | Benign (Jan 07, 2024) | ||
7-30912049-A-G | Uncertain significance (Jun 17, 2023) | |||
7-30912057-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
7-30912089-C-T | AQP1-related disorder | Benign (Jan 16, 2024) | ||
7-30912094-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
7-30912095-G-A | Likely benign (Dec 07, 2023) | |||
7-30912128-C-T | Likely benign (Dec 24, 2021) | |||
7-30912192-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
7-30912216-G-C | not specified | Uncertain significance (Jul 30, 2023) | ||
7-30912228-G-A | AQP1-related disorder | Benign (Aug 17, 2023) | ||
7-30912229-T-G | Benign (Nov 27, 2023) | |||
7-30912230-C-T | Likely benign (Dec 12, 2023) | |||
7-30921380-G-A | Benign (May 10, 2021) | |||
7-30922056-T-A | Benign (Dec 28, 2021) | |||
7-30922085-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
7-30922086-G-A | Benign (Jul 16, 2023) | |||
7-30922105-G-A | not specified | Uncertain significance (Dec 13, 2021) | ||
7-30922134-A-G | Likely benign (Jan 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AQP1 | protein_coding | protein_coding | ENST00000311813 | 4 | 72122 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0933 | 0.873 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.544 | 156 | 176 | 0.885 | 0.0000119 | 1730 |
Missense in Polyphen | 73 | 87.404 | 0.8352 | 867 | ||
Synonymous | -0.851 | 92 | 82.2 | 1.12 | 0.00000654 | 592 |
Loss of Function | 1.81 | 3 | 8.80 | 0.341 | 4.81e-7 | 82 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000708 | 0.0000703 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Forms a water-specific channel that provides the plasma membranes of red cells and kidney proximal tubules with high permeability to water, thereby permitting water to move in the direction of an osmotic gradient. {ECO:0000269|PubMed:1373524}.;
- Pathway
- Bile secretion - Homo sapiens (human);Proximal tubule bicarbonate reclamation - Homo sapiens (human);Renin secretion - Homo sapiens (human);Polythiazide Action Pathway;Methyclothiazide Action Pathway;Bumetanide Action Pathway;Spironolactone Action Pathway;Eplerenone Action Pathway;Triamterene Action Pathway;Amiloride Action Pathway;Ethacrynic Acid Action Pathway;Quinethazone Action Pathway;Bendroflumethiazide Action Pathway;Chlorthalidone Action Pathway;Trichlormethiazide Action Pathway;Iminoglycinuria;Lysinuric Protein Intolerance;Blue diaper syndrome;Lysinuric protein intolerance (LPI);Cystinuria;Indapamide Action Pathway;Furosemide Action Pathway;Torsemide Action Pathway;Hartnup Disorder;Glucose Transporter Defect (SGLT2);Kidney Function;Glucose Transporter Defect (SGLT2);Metolazone Action Pathway;Hydrochlorothiazide Action Pathway;Cyclothiazide Action Pathway;Hydroflumethiazide Action Pathway;Chlorothiazide Action Pathway;Spinal Cord Injury;O2/CO2 exchange in erythrocytes;Transport of small molecules;Erythrocytes take up oxygen and release carbon dioxide;Erythrocytes take up carbon dioxide and release oxygen;Passive transport by Aquaporins;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.406
Intolerance Scores
- loftool
- 0.111
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.15
Haploinsufficiency Scores
- pHI
- 0.705
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.476
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.755
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Aqp1
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; skeleton phenotype; renal/urinary system phenotype;
Zebrafish Information Network
- Gene name
- aqp1a.1
- Affected structure
- vH ionocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased process quality
Gene ontology
- Biological process
- renal water homeostasis;renal water transport;potassium ion transport;water transport;cell volume homeostasis;hyperosmotic response;carbon dioxide transport;ammonium transport;bicarbonate transport;glycerol transport;cellular homeostasis;cGMP-mediated signaling;lateral ventricle development;pancreatic juice secretion;nitric oxide transport;establishment or maintenance of actin cytoskeleton polarity;cerebrospinal fluid secretion;cellular response to UV;transepithelial water transport;carbon dioxide transmembrane transport;odontogenesis;response to drug;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of angiogenesis;positive regulation of saliva secretion;positive regulation of fibroblast proliferation;multicellular organismal water homeostasis;cellular response to hydrogen peroxide;cellular response to inorganic substance;cellular response to mechanical stimulus;cellular response to copper ion;cellular response to mercury ion;cellular response to retinoic acid;cellular response to cAMP;cellular response to hypoxia;cellular response to salt stress;cellular hyperosmotic response;cellular response to dexamethasone stimulus;cellular response to nitric oxide;potassium ion transmembrane transport;ammonium transmembrane transport;maintenance of symbiont-containing vacuole by host
- Cellular component
- nucleus;cytoplasm;plasma membrane;integral component of plasma membrane;brush border;basal plasma membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane;symbiont-containing vacuole;symbiont-containing vacuole membrane;brush border membrane;nuclear membrane;sarcolemma;apical part of cell;extracellular exosome
- Molecular function
- intracellular cGMP-activated cation channel activity;potassium channel activity;water transmembrane transporter activity;protein binding;ammonium transmembrane transporter activity;potassium ion transmembrane transporter activity;glycerol transmembrane transporter activity;water channel activity;transmembrane transporter activity;nitric oxide transmembrane transporter activity;carbon dioxide transmembrane transporter activity;identical protein binding